Teda International Cardiovascular Hospital

Tianjin 300457

2 studies enrolling now · 6 studies all time

What they study most

Acute Coronary Syndrome, Acute Myocardial Infarction, Atherosclerotic Cardiovascular Disease (ASCVD), Atrial Fibrillation, Elevated Lp(a), Lipoprotein Disorder, Myocardial Infarction, Prevention of Stroke or Systemic Embolism

Studies at this site

• Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a) — Recruiting now
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early